Vir Biotechnology Inc. (VIR) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
11:19 am
Sale
2022-02-1413GVIR BIOTECHNOLOGY INC
VIR
Capital International Investors5,634,019
4.300%
-5,806,552decrease
(-50.75%)
Filing
History
2022-02-10
4:46 pm
Purchase
2021-12-3113GVIR BIOTECHNOLOGY INC
VIR
GSK plc8,550,954
6.500%
1,924,927increase
(+29.05%)
Filing
History
2022-02-10
08:42 am
Purchase
2021-12-3113GVIR BIOTECHNOLOGY INC
VIR
VANGUARD GROUP INC7,330,131
5.600%
7,330,131increase
(New Position)
Filing
History
2022-01-10
5:02 pm
Sale
2021-12-2013DVIR BIOTECHNOLOGY INC
VIR
ARCH Venture Fund IX, L.P.19,185,720
14.700%
-2,589,653decrease
(-11.89%)
Filing
History
Goto Prev, 0, 1